🇺🇸 FDA

Intelligence · Patent portfolio

Regeneron Ireland Designated Patents

Full USPTO pharma patent portfolio for Regeneron Ireland Designated — grant dates, expiration, and drug cross-links.

Patents
8,292
Expiring ≤24m
426

Quick answer

Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months — use filters for patent-cliff planning.

Page 157 of 173

  1. US 6559189

    Non-toxic antimicrobial compositions and methods of use

    Expires Mon May 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  2. US 6555347

    Human minor vault protein p193

    Expires Mon Apr 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  3. US 6555582

    Eye treatments using synthetic thyroid hormone compositions

    Expires Mon Apr 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  4. US 6555116

    Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin

    Expires Mon Apr 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  5. US 6551588

    Tumor radiosensitization using gene therapy

    Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  6. US 6551830

    Rh blood group antigen compositions and methods of use

    Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  7. US 6551989

    Preventing airway mucus production by administration of EGF-R antagonists

    Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 6551774

    Diagnostic methods for conditions associated with elevated cellular levels of telomerase activity

    Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  9. US 6548521

    Inhibitors of metazoan parasite proteases

    Expires Mon Apr 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  10. US 6548679

    Antitumor agents

    Expires Mon Apr 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  11. US 6544757

    Synthesis of human virus antigens by yeast

    Expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  12. US 6545123

    Synthetic glycosulfopeptides and methods of synthesis thereof

    Expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  13. US 6544972

    Methods of limiting apoptosis of cells

    Expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 6545034

    Use of etodolac for the treatment of chronic lymphocytic leukemia

    Expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  15. US 6544956

    Lunasin peptides

    Expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  16. US 6544528

    Multi-subtype FIV vaccines

    Expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  17. US 6544750

    Peptide analogs as selective inhibitors of thrombin activation of protease activated receptor 1

    Expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  18. US 6541195

    Correction of genetic defects using chemical chaperones

    Expires Mon Mar 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 6541212

    Methods for detecting prostate stem cell antigen protein

    Expires Mon Mar 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6537814

    Compositions and methods for altering the biodistribution of biological agents

    Expires Mon Mar 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  21. US 6537804

    BCR-ABL directed compositions and uses for inhibiting Philadelphia chromesome stimulated cell growth

    Expires Mon Mar 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  22. US 6537768

    Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC panca antigens

    Expires Mon Mar 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  23. US 6534062

    Methods for increasing a cytotoxic T lymphocyte response in vivo

    Expires Mon Mar 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  24. US 6534310

    Suppression of proteolytic activity by dysfunctional protease formation

    Expires Mon Mar 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  25. US 6534283

    Method for treatment and prevention of physiological shock

    Expires Mon Mar 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  26. US 6534676

    Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same

    Expires Mon Mar 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  27. US 6531455

    Delivery of polynucleotides by secretory gland expression

    Expires Mon Mar 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  28. US 6531506

    Inhibitors of epoxide hydrolases for the treatment of hypertension

    Expires Mon Mar 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  29. US 6531292

    Genes and proteins controlling cholesterol synthesis

    Expires Mon Mar 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  30. US 6528284

    Polynucleotides encoding proteins mediating switch recombination

    Expires Mon Feb 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 6528059

    Thyroid peroxidase epitopic regions

    Expires Mon Feb 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  32. US 6528087

    Kits for forming protein-linked lipidic microparticles

    Expires Mon Feb 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  33. US 6528487

    Peptide inhibitors of inflammation mediated by selectins

    Expires Mon Feb 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  34. US 6524585

    Indolicidin analogs and methods of using same

    Expires Mon Feb 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  35. US 6524613

    Hepatocellular chimeraplasty

    Expires Mon Feb 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  36. US 6525062

    Method of treating pain using nalbuphine and opioid antagonists

    Expires Mon Feb 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  37. US 6524583

    Antibody methods for selectively inhibiting VEGF

    Expires Mon Feb 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  38. US 6521615

    Diagnosing an animal for pyrophosphate gout, osteoporosis, or osteoarthritis by assaying intracellular pyrophosphate content in peripheral blood cells

    Expires Mon Feb 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  39. US 6518259

    Compositions for treating autoimmune disease

    Expires Mon Feb 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  40. US 6518063

    Osf2/Cbfa1 nucleic acids and methods of use therefor

    Expires Mon Feb 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  41. US 6517808

    Methods for boron delivery to mammalian tissue

    Expires Mon Feb 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  42. US 6517839

    Methods for inducing interleukin-12 and a type1/Th1 T-cell response

    Expires Mon Feb 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  43. US 6517828

    C-CAM as an angiogenesis inhibitor

    Expires Mon Feb 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  44. US 6517855

    Method of sterilizing

    Expires Mon Feb 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  45. US 6518480

    Selective target cell activation by expression of a G protein-coupled receptor activated superiorly by synthetic ligand

    Expires Mon Feb 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  46. US 6514696

    Transcriptionally regulated G protein-coupled receptor G2A

    Expires Mon Jan 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  47. US 6515118

    DNA fragmentation factor

    Expires Mon Jan 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  48. US 6515113

    Phthalamide lanthanide complexes for use as luminescent markers

    Expires Mon Jan 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Regeneron Ireland Designated have?

8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron Ireland Designated patents expire?

426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.